Human endothelial nitric oxide synthase (eNOS), that is constitutively expressed primarily in endothelial cells lining blood vessels and hearts, has been known to play an important role in regulating blood pressure, vascular permeability, white blood cell adhesion and platelet aggregation, contributing to some pathological processes such as shock, hypertension, atherosclerotic heart disease, diabetes, ischaemia, vascular stenosis and occlusion [1, 2, 4, 8, 12, 14, 19, 28] 
Expression of eNOS gene is up-regulated or down-regulated by a variety of exogenous and endogenous stimuli
, at least including shear stress [40] , hypoxia [17, 18, 36, 37] , lysophosphatidylcholine (LPC) [6, 42, 43] , oxidized low density lipoprotein [15] , histamine [23, 38] , ceramide [24] , flavonoid [3] , resveratrol [39] , transforming growth factor-␤ [35] , tumour necrosis factor-␣ [20] and estrogen [27, 41] [6, 42] , was involved in up-regulation of eNOS gene expression. [15, 21, 30] [7, 42] [13, 43] 
Strong evidence supports a role for LPC, which is a product of phosphatidylcholine hydrolysis by phospholipase A2 (PLA2), in the processes of atherogenesis, inflammation, and vascular wound healing

. It was demonstrated that LPC increased eNOS expression, representing a crucial mechanism by which arteries exert their plastic defence against vessel wall injury and atherogenesis, and therefore it has been used as a model system to illuminate the mechanism by which eNOS gene transcription is regulated
. In the present study, to shed light on the regulation of human eNOS gene expression, a red fluorescent protein (RFP) reporter gene vector containing human eNOS promoter was successfully constructed and co-transfected with wild-type MAPKs and their up-stream active mutants as well as decoy oligonucleotides (ODN) into human umbilical vein endothelial cells. Using RFP as a reporter
, real time observation could be carried out to detect the activity of eNOS promoter in the cells treated with LPC. The novel findings suggest that the upregulation of human eNOS gene transcription is implicated not only in ERK1/2, but also in JNK1/2 signalling pathway, and p38 signalling pathway exerts its effort on down-regulation of it.
Materials and methods
Construction of expression vectors
Statistical analysis
All the data were expressed as mean Ϯ standard deviation. Fig. 1E and F) . Fig. 2A and B) , and curcumin might also abrogate the induction of the JNK1 phosphorylation by LPC (Fig. 2C and D) . But the phosphorylation level of p38 MAPK was not altered by treatment with LPC no matter in the presence or absence of SB203580 ( Fig. 2E and F (Fig. 3A) .
Results
Induction of human eNOS transcriptional activity by LPC
To check effect of LPC on gene expression of human eNOS, an eNOS promoter-driven RFP reporter gene expression vector was constructed. It was found that this RFP reporter system was well expressed in HUVEC-12 cells. After the stimulation of LPC (40 Mol/l), RFP expression was elevated significantly as compared with the untreated cells (P < 0.01).
Selective induction of the phosphorylation of MAPKs by LPC
Effect of MAPK inhibitors on the phosphorylation of MAPKs induced by LPC
To further confirm the inducing action of LPC on the phosphorylation of MAPKs above, MEK1-selective inhibitor PD98059, JNKselective inhibitor curcumin and p38-specific inhibitor SB203580 were administered to HUVEC-12 cells before treatment of LPC, respectively. The results showed that the increase of the phosphorylation level of ERK1/2 by stimulation of LPC might be abolished by PD98059 (
Effect of MAPK activation on human eNOS transactivity
In (Fig. 3B) . (Fig. 4A) . (Fig. 4B) . Fig. 5A and B) . Fig. 5C and D) . Fig. 6A and B) . These results suggested that ERK1/2 and JNK pathways were implicated in SP1 DNA binding activity induced by LPC.
Effect of MAPK inhibitors on LPC-induced human eNOS transactivity
MAPK inhibition on the eNOS gene expression induced by LPC. The results showed that the human eNOS promoter activity induced by LPC was dramatically blocked by both PD98059 and curcumin. However, SB203580 lacked the ability to repress the induction of the promoter transactivity by treatment with LPC. These results showed that ERK1/2 and JNK signal pathways might be involved in the activation of the promoter transactivity induced by LPC
The human eNOS promoter activity induced by LPC in HUVEC-12 cells that were co-transfected with the pDseNOSRed plus JNK1 expression vector was higher than that in the cells that were cotransfected with pDseNOSRed plus pcDNA3 vector. Furthermore, JNK activation-induced eNOS expression was also blocked by curcumin, strongly suggesting that JNK pathway is indeed associated with the up-regulation of the promoter transcription induced by LPC
LPC-induced SP1 and AP1 DNA binding activities
To confirm activities of SP1 DNA binding in HUVEC-12 cells stimulated by LPC, the nuclear extracts at the different time were subjected to EMSA analysis. SP1 DNA binding activity began to go up 15 min. after treatment of LPC, reaching the peak 1 to 3 hrs after LPC treatment, followed by a gradual decrease 4 hrs after the treatment (
AP1 DNA binding activity swiftly reached the peak at 30 min. after treatment of LPC and maintained at a high level up to 4 hrs after LPC treatment, followed by a decrease 6 hrs after the treatment of LPC. The result indicates that LPC may enhance both SP1and AP1 DNA binding activities in HUVEC-12 cells (
Effect of MAPK inhibitors on LPC-induced SP1 and AP1 DNA binding activities
Both PD98059 and curcumin blocked SP1 DNA binding activity induced by LPC, but SB203580 failed to show any inhibitory effect on the SP1 DNA binding activity (
As shown in Figure 6C and
D, PD98059 could not block AP1 DNA binding activity induced by LPC, but curcumin could do it markedly, suggesting that JNK signalling pathway may involve the AP1 DNA binding activity induced by LPC. Although SB203580 could also inhibit the AP1 DNA binding activity induced by LPC, it had no significant influence on the promoter transactivity by induction of LPC, suggesting that the
Fig. 3 Effect of the stimulation of LPC and the activation of MAPKs on human eNOS transcriptional activity. (A) Cultured HUVEC-12 cells were co-transfected with pDseNOSRed plus pcDNA3 or ERK2 or JNK1 or p38 MAPK expression vector, respectively. (B) The cultured cells were co-transfected with pDseNOSRed plus pcDNA3 or MEK1(E) or MKK4(E) or MKK6b(E) active mutant, respectively. These cells were treated with or without stimulation of LPC (40 Mol/l) 45 hrs after the transfection. The red fluorescence-emitting cells were subjected to dynamic observation under an inverted fluorescence microscope. The fluorescence intensity of RFP expressed by the cells that represents the eNOS transactivity was quantitatively analysed using the fluorescence analysis software, Image-Pro Plus, 96 hrs after transfection. This result represents means Ϯ S.D. of 3 independent
experiments. *P < 0.05, **P < 0.01, compared with pDseNOSRed group. Fig. 7A and B) (Fig. 7C and D) .
reduction of the AP1 DNA binding activity by SB203580 is not associated with the enhancement of the LPC-stimulated transactivity.
Effect of MAPK inhibitors on LPC-induced SP1 and AP1 DNA binding activities in the presence of JNK1 overexpression
From the results above, it is reasonable to speculate that JNK plays a key role in the regulation of eNOS gene expression in LPCinduced physiological or pathological processes. We would like to check effect of JNK on the SP1 and AP1 DNA binding activities in HUVEC-12 cells. It was found that the overexpression of JNK1 in the cells increased the both SP1 and AP1 DNA binding activities, and also further boosted the LPC-induced SP1 and AP1 DNA binding activities (
Effect of decoy ODNs of AP1, SSRE and SP1 on human eNOS transactivity
To further analyse the response element in human eNOS promoter that involved the regulation of eNOS gene transcription, several typical decoy ODNs were used to evaluate the contribution of AP1, SSRE and SP1 in LPC-induced eNOS transcription.
It was found that SP1 decoy ODN down-regulated significantly not only the basal activity of the promoter, but also the stimulated activity of it. By contrast, the control ODN with the mutated sequence of SP1 promoted the recovery of the promoter activity inhibited by the application of SP1 decoy ODN (Fig. 8B) . Although AP1 decoy ODN appeared the influence just on the stimulated activity of the promoter, the action was not as effective as the decoy ODN of wild-type of SP1 (Fig. 8A) . As speculated by us, SSRE decoy ODN failed to exert any influences on the promoter activity (Fig. 8C ). All these data suggested that the basal and stimulated transcriptional activity of human eNOS promoter was regulated by SP1 transcription factor, although we could not exclude the role of AP1 transcription factor in the regulation of the stimulated transactivity of it.
Fig. 4 Effects of the selective inhibitors of MAPKs on human eNOS transcriptional activity induced by LPC. (A) After transfected with pDseNOSRed, HUVEC-12 cells were treated without or with PD98059 (50
Discussion
Lysophosphatidylcholine (LPC), as a prominent phospholipid component of OxLDL, is responsible for various biological activities of OxLDL, such as regulation of adhesion molecules, NO,
cytokines, and growth factors [25, 31, 33] . Recently, several lines of evidence showed that eNOS expression was up-regulated by LPC [32, 43, 44] . However, it was not clear how MAPK signalling transduction pathways elicit their actions on the up-regulation of eNOS induced by LPC [1, 11, 43] . In the current study, using RFP reporter gene containing human eNOS promoter we proved that eNOS gene transactivity was up-regulated by the stimulation of LPC. 7~9 (A, B) and 6~8 (C, D) 
Cieslik et al. showed that LPC selectively induced ERK1/2 phosphorylation in a time-and concentration-dependent manner without altering their protein levels, followed by the up-regulation of eNOS transcription activation, but that it did not induce phosphorylation of JNK or p38 MAPK [6]. Faustino's research group also demonstrated that LPC activated ERK 1/2 MAPK pathway
